Isocitrate dehydrogenase 1 (IDH1) mutations, which lead to the accumulation of the oncometabolite 2‐hydroxyglutarate (2‐HG), are frequently observed in chondrosarcoma, particularly in the conventional (diffuse‐type) subtype. This evidence concerns the gene IDH1 and chondrosarcoma.